Asthma patients with specific genotypes identified for fish oil

California Agriculture

Volumn 65, Issue 3, 2011, Pages 112-117

  Fortenko, Olga ^a   Zeki, Amir ^a   Schuster, Gertrud ^a,b   Davis, Cristina ^a   Allayee, Hooman ^c   Stephensen, Charles ^b   Kenyon, Nicholas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861404234     PISSN: 00080845     EISSN: None     Source Type: Journal    
DOI: 10.3733/ca.v065n03p112     Document Type: Article

References (23)

1. Baraldi E, Carraro S, Giordano G, et al. 2009. Metabolomics moving toward personalized medicine. Ital J Pediatr 35(1):30.
2. Brasier AR, Victor S, Boetticher G, et al. 2008. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 121:30-7.
3. Calder PC. 2006. N-3 polyunsaturated fatty acids, inflammation and inflammatory diseases. Am J Clin Nutr 83(6 Suppl):1505-19S.
4. [CDC] Centers for Disease Control and Prevention. National Center for Health Statistics, Asthma prevalence, healthcare use and mortality, 2002. www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.html.
5. [CDPH] California Department of Public Health. 2008. Strategic Plan for Asthma in California-2008-2012. www.cdph.ca.gov/programs/CAPHI/Documents/ AsthmaStrategicPlan.5-5-08.pdf. 98 p.
6. Hodge L, Salome CM, Peat JK, et al. 1996. Consumption of oily fish and childhood asthma risk. Med J Austr 164:137-40.
7. Kharitonov SA, Barnes PJ. 2006. Exhaled biomarkers. Chest 130:1541-6.
8. Klotsman M, York T P, Sreekumar G P, et al. 2007. Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet Genomics 17:189-96.
9. Koshino T, Takano S, Houjo T, et al. 1998. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics. Biochem Biophys Res Comm 247(2):510-3.
10. Koshino T, Takano S, Kitani S, et al. 1999. Novel polymorphism of the 5-lipoxygenase activating protein (FLAP) promoter gene associated with asthma. Mol Cell Biol Res Comm 2(1):32-5.
11. Kostikas K, Koutsokera A, Papiris S, et al. 2008. Exhaled breath condensate in patients with asthma: Implications for application in clinical practice. Clin Exp Allergy 38:557-656.
12. Lima JJ, Zhang S, Grant A, et al. 2006. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173(4):379-85.
13. McFadden ER, Hejal RB. 2000. The pathobiology of acute asthma. Clin Chest Med 21(2):213-24.
14. Mealey FH, Kenyon NJ, Avdalovic MV, Louie S. 2007. Difficult-to-control asthma in adults. Am J Med 120(9):760-3.
15. Meng YY, Babey SH, Malcolm E, et al. 2003. Asthma in California: Findings from the 2001 California Health Interview Survey. UCLA Center for Health Policy Research. www.healthpolicy.ucla.edu/pubs/files/Asthma-Rpt-FINAL-R.pdf.
16. Mofatt MF. 2008. Genes in asthma: New genes and new ways. Curr Opin Allergy Clin Immunol 8:411-7.
17. [NIH] National Institutes of Health. 2007. Guidelines for the Diagnosis and Management of Asthma (EPR-3). National Heart and Lung Blood Institute. Bethesda, MD. www.nhlbi.nih.gov/guidelines/asthma.
18. Ogawa Y, Calhoun WJ. 2006. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 118(4):789-98.
19. Samitas K, Chorianopoulos D, Vittorakis S, et al. 2009. Exhaled cysteinyl-leukotrienes and 8-isoprostanes in patients with asthma and their relation to clinical severity. Respir Med 103(5):750-6.
20. Tantisira KG, Drazen JM. 2009. Genetics and pharmacogenetics of the leukotriene pathway. J Allergy Clin Immunol 124:422-7.
21. Ueno T, Kataoka M, Hirano A, et al. 2008. Inflammatory markers in exhaled breath condensate from patients with asthma. Respirology 13:654-63.
22. Warrier MR, Khurana Hershey GK. 2008. Asthma genetics: Personalizing medicine. J Asthma 45:257-64.
23. Wong KA. 2005. Clinical efficacy of n-3 fatty acid supplementation in patients with asthma. J Am Diet Assoc 105:98-105.